Regulations Governing Subsidies for Treatment Expenses of HIV-Infected Persons Article 6

Items of which designated medical institutions may apply for the subsidies are as follows:1. HIV treatment-related expenses including diagnostic fees during outpatient and inpatient care.2. Expenses of antiretroviral medications.3. Pharmaceutical service fees on antiretroviral medications.4. Laboratory service fees on tests for HIV viral load and CD4 cell count.5. Other items designated by the central competent authorities.The subsidies baselines of the preceding Paragraph are as follows:1. By the items and fee schedules formulated by the central competent authority.2. By The National Health Insurance Medical Service Items and Fee Schedule.3. By The National Health Insurance Pharmaceutical Benefits and Reimbursement Schedule.Prescriptions of antiretroviral medications formulated in Sub-paragraph 2 and Sub-paragraph 4 of Paragraph 1 shall be in accordance with the regulations formulated by the central competent authority.When applying for subsidies of Paragraph 1, designated medical institutions shall present laboratory testing reports, examination reports and relevant information of the tested or the infected.
中文原文 人類免疫缺乏病毒感染者治療費用補助辦法第6條
指定醫事機構得申請費用補助之項目如下:
一、人類免疫缺乏病毒門診及住院診察費等治療相關之醫療費用。
二、抗人類免疫缺乏病毒之藥品費。
三、抗人類免疫缺乏病毒藥品之藥事服務費。
四、病毒負荷量檢驗與感染性淋巴球檢驗之檢驗費。
五、其他經中央主管機關指定之項目。
前項費用補助項目之支付基準如下:
一、依中央主管機關訂定之支付品項及價格。
二、依全民健康保險醫療服務給付項目及支付標準。
三、依全民健康保險藥物給付項目及支付標準。
第一項第二款及第四款規定之抗人類免疫缺乏病毒之處方,依中央主管機關之規定。
指定醫事機構申請第一項之費用時,應提報受檢者或感染者之檢驗、檢查報告及相關資料。

English translation for reference only; the Chinese text prevails. Not legal advice.